Action 0QIU NOVO NORDISK A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Novo Nordisk A/S London S.E.

Actions

0QIU

DK0062498333

Marché Fermé - London S.E.
Autres places de cotation
 16:55:00 28/06/2024 		Varia. 5j. Varia. 1 janv.
1 015 DKK +1,67% Graphique intraday de Novo Nordisk A/S +2,62% +45,33%
28/06 L'Inde prévoit des mesures d'incitation pour les fabricants de médicaments contre le diabète et l'obésité en 2026, selon un responsable gouvernemental RE
28/06 NOVO NORDISK : UBS confirme sa recommandation neutre ZD

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss
GL
New US fill finish facility receives $4.1 billion investment
AQ
Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery
AQ
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline
GL
Novo Nordisk A/S - share repurchase programme
GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month
AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association
GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says
AQ
Novo Nordisk A/S - share repurchase programme
GL
Haemophilia drug could reduce treated bleeding episodes
AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)
AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
AQ
Novo Nordisk A/S - share repurchase programme
GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors
AQ
Novo Nordisk A/S - share repurchase programme
GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results
AQ
Novo Nordisk A/S - share repurchase programme
GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
AQ
Novo Nordisk A/S - share repurchase programme
GL
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
GL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action NOVO B
  4. Action 0QIU
  5. Actualités Novo Nordisk A/S
  6. Communiqués